FOXM1 and glioblastoma: The clinical significance of FoxM1 splicing is further strengthened by the facts that the FoxM1c/FoxM1b ratio is upregulated in MES‐GBM compared with PN‐GBM, and high‐level FoxM1c predicts poor survival in GBM (Figure 6g,h).